[
  {
    "question": "seizure with chocking, where is the localization:",
    "option_a": "Mesial temporal sclerosis.",
    "option_b": "Insula",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Localization of seizure onset is primarily derived from seizure semiology. In this case, the choking sensation points to involvement of brain regions responsible for autonomic and visceral sensations. The insula is a key region that integrates somatosensory, visceral, and autonomic inputs. The insula, especially its anterior portion, plays a major role in processing interoceptive signals including those related to swallowing and airway sensations. Abnormal neuronal discharges in the insular cortex can produce autonomic disturbances such as a choking sensation, as well as alterations in cardiovascular function. Recent evidence shows that insular epileptic foci are often associated with atypical sensory and autonomic symptoms. Patients with insular seizures may present with unusual visceral sensations including throat constriction or choking. This contrasts with mesial temporal lobe seizures where the aura is more often emotional (fear, d\u00e9j\u00e0 vu) or experiential. Recognizing the choking complaint is therefore critical in suspecting an insular onset. Localizing the focus involves video-EEG monitoring combined with high-resolution imaging (MRI). Differential diagnoses include mesial temporal lobe epilepsy, which typically has a different semiology (e.g., olfactory hallucinations, d\u00e9j\u00e0 vu). In some cases, invasive monitoring (like depth electrodes) may be used to better delineate the insular involvement. First-line management typically involves antiepileptic drugs (AEDs) targeted for focal seizures (e.g., levetiracetam, lamotrigine). In cases refractory to medical therapy, surgical evaluation and possible resection of the insular focus may be considered. In pregnancy and lactation, AED choice is guided by safety profiles (lamotrigine and levetiracetam are preferred) and risk\u2010benefit discussions. Option A (Mesial temporal sclerosis) is incorrect because mesial temporal seizures usually present with experiential auras and automatisms rather than a choking sensation. Options C and D are not provided, leaving Option B (Insula) as the best match based on the autonomic choking symptoms observed. 1. Insular seizures can mimic autonomic or visceral events, such as a choking sensation. 2. Detailed semiologic analysis and correlation with EEG findings are essential. 3. Consider insular epilepsy in patients with atypical autonomic symptoms. Recent studies emphasize the importance of the insula in integrating autonomic responses. Improved imaging techniques and intracranial recordings have helped in localizing insular foci, which often exhibit symptoms uncommon to other epilepsy types.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "what is the EEG findings has poor prognosis:",
    "option_a": "Non reactive continuous Alpha.",
    "option_b": "FIRDA",
    "option_c": "Hypsarrhythmia.",
    "option_d": "Continuous spindles.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Certain EEG patterns serve as prognostic indicators in patients with severe brain injury or encephalopathy. The alpha coma pattern, characterized by a nonreactive continuous alpha rhythm, is one such pattern known to be associated with poor outcomes. In the alpha coma pattern, diffuse cortical dysfunction\u2014especially following hypoxic or anoxic brain injury\u2014leads to the emergence of nonreactive alpha-frequency activity. This pattern reflects a severe loss of cortical responsiveness and is associated with extensive brain damage. Patients exhibiting a nonreactive continuous alpha rhythm (alpha coma) typically have a very poor prognosis. In contrast, other patterns like FIRDA (frontal intermittent rhythmic delta activity) or hypsarrhythmia (associated with infantile spasms) have different clinical contexts and prognostic implications. EEG is the primary diagnostic test. Differential considerations include: FIRDA, which, though nonspecific, may be seen in metabolic or toxic encephalopathies; hypsarrhythmia, typically seen in infants with West syndrome; and continuous spindles, which are usually found in normal or sleep states. Clinical context and EEG reactivity are key for differentiation. Management of patients with an alpha coma pattern primarily involves supportive care and critical care interventions. Prognostic discussions and decisions regarding further management are guided by the severity of brain injury. In pregnant or lactating patients, supportive measures remain the mainstay and care is taken to avoid interventions that could further compromise maternal or fetal safety. Option A (Non reactive continuous Alpha) is correct, as this pattern (alpha coma) is a well-recognized poor prognostic indicator. Option B (FIRDA) is less specific and not directly correlated with poor prognosis. Option C (Hypsarrhythmia) is seen in pediatric epileptic encephalopathy and has a different management pathway. Option D (Continuous spindles) is typically a normal finding in sleep or in post-anoxic conditions with preserved function. 1. A nonreactive continuous alpha rhythm (alpha coma) is often associated with severe brain injury and a poor outcome. 2. EEG reactivity is a crucial factor in prognostication. 3. Differentiation among EEG patterns is key to appropriate management and prognostication. Recent guidelines in post-cardiac arrest care emphasize the use of continuous EEG monitoring to detect alpha coma patterns, which remain a reliably poor prognostic marker despite advances in supportive therapies.",
    "exam_year": "2019",
    "exam_type": "Promotion",
    "image_url": "page_20.png"
  },
  {
    "question": "young patient has sudden decrease LOC, he has jerky movement with no post ictal confusion, preceded by lightheadedness & became pale. what is the diagnosis?",
    "option_a": "Syncope",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Syncope is defined as a transient loss of consciousness due to cerebral hypoperfusion. It often presents with features that may mimic seizures, such as brief myoclonic jerks, without the prolonged postictal phase seen in true epileptic seizures. The transient drop in cerebral perfusion during syncope can lead to brief, involuntary jerking (convulsive syncope), which is caused by hypoxic neuronal dysfunction. Unlike epileptic seizures, there is no abnormal, sustained cortical electrical discharge. Key differentiating features include the presence of typical prodromal symptoms\u2014lightheadedness and pallor\u2014and the absence of a postictal state. In epileptic seizures, patients usually experience a period of confusion or disorientation afterward, a feature lacking in syncope. Diagnosis is primarily clinical, aided by a detailed history noting triggers, prodromal symptoms, and the brief duration of jerky movements. Differential diagnoses include epileptic seizures and transient ischemic attacks (TIA). In equivocal cases, tests such as tilt-table testing, ECG, and EEG (to rule out seizures) may be performed. Management focuses on identifying and remedying the underlying cause. For vasovagal (neurally mediated) syncope, lifestyle modifications such as hydration, avoidance of triggers, and physical counterpressure maneuvers are first-line treatments. In recurrent cases, medication (e.g., beta-blockers) may be considered. In pregnant or lactating patients, treatment remains supportive with careful evaluation of triggers and maneuvers to prevent episodes. Option A (Syncope) is correct because the clinical history (sudden loss of consciousness, brief jerky movements without postictal confusion, and prodromal symptoms of lightheadedness and pallor) is characteristic of syncope rather than an epileptic event. Other options are not provided. 1. Convulsive movements during syncope (convulsive syncope) are not uncommon and do not necessarily indicate an epileptic seizure. 2. The absence of a postictal period is a crucial distinguishing factor. 3. A thorough history is vital to differentiate between syncope and seizure. Recent research reinforces the utility of tilt-table testing and detailed clinical history in diagnosing vasovagal syncope. Additionally, current guidelines stress avoiding over-treatment with antiepileptic drugs in patients who present with convulsive syncope.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "seizure semiology: flexion in one limb with extension of the other limb & head turning to the extended limb, where is the localization:",
    "option_a": "orbitofrontal.",
    "option_b": "Temporal.",
    "option_c": "Dorsolateral frontal",
    "option_d": "SMA",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Seizure semiology provides important clues localizing the epileptogenic zone. In focal motor seizures, the nature of motor posturing and head turning can help distinguish between different frontal lobe regions. Discharges in the dorsolateral frontal region (which includes the primary motor cortex) can cause focal motor phenomena such as asymmetric tonic posturing. The described pattern of flexion in one limb with extension in the other, together with head turning toward the extended limb, is consistent with activation of contralateral motor pathways, typically seen in dorsolateral frontal seizures. This semiologic pattern suggests that the seizure focus is in the part of the frontal lobe that directly controls movement. Unlike seizures originating in the supplementary motor area (SMA), which tend to produce more symmetric or bilateral motor phenomena, dorsolateral frontal seizures more commonly present with lateralized motor signs including directional head turning. Diagnosis is based on careful video-EEG monitoring correlating clinical semiology with electrographic findings. Differential diagnoses include orbitofrontal seizures (often associated with affective or behavioral changes), temporal lobe seizures (with automatisms and altered awareness), and SMA seizures (more bilateral in nature). First-line management for focal seizures typically involves AEDs such as levetiracetam, lamotrigine, or carbamazepine. If seizures are refractory, surgical evaluation for resection of the epileptogenic zone may be considered. In pregnancy and lactation, drugs like lamotrigine and levetiracetam are preferred due to their relatively favorable safety profiles, with careful monitoring and dose adjustments as pregnancy progresses. Option A (orbitofrontal) is less likely because orbitofrontal seizures primarily manifest with behavioral and cognitive symptoms rather than distinct motor posturing. Option B (temporal) usually presents with automatisms and altered awareness rather than clear unilateral motor signs. Option D (SMA) seizures typically produce bilateral or symmetric motor phenomena lacking the lateralized head turning. Option C (dorsolateral frontal) is most consistent with the unilateral and asymmetric motor features described. 1. Asymmetric tonic posturing with head turning is a key lateralizing sign for focal motor seizures originating in the dorsolateral frontal cortex. 2. Video-EEG correlation is essential in localizing the seizure onset zone. 3. Differentiating between SMA and lateral frontal seizures is critical for appropriate surgical planning. Recent studies underscore the importance of semiologic analysis in epilepsy surgery. Advanced imaging and neurophysiological data further support the role of the dorsolateral frontal region as the origin of specific motor seizures, aiding in improved surgical outcomes when medical management fails.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "phenytoin with VA what is the effect:",
    "option_a": "increase the phenytoin level.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question tests your understanding of drug\u2013drug interactions between antiepileptic medications. Phenytoin is highly protein\u2010bound and exhibits nonlinear kinetics. Valproic acid (VA) can displace phenytoin from plasma protein binding sites and also inhibit its hepatic metabolism, making it a classic example of how one AED can affect the serum level of another. Phenytoin is metabolized by hepatic enzymes and is normally 90%+ protein\u2010bound. When VA is administered concurrently, it displaces phenytoin from its binding sites and also interferes with phenytoin\u2019s metabolism. This results in an increased free (active) fraction of phenytoin. Due to phenytoin\u2019s saturable kinetics, even small increases in the free fraction may lead to disproportionately high total levels and clinical toxicity. The clinical result of this interaction is an increased risk of phenytoin toxicity. Patients may exhibit signs such as nystagmus, ataxia, diplopia, and altered mental status when levels become supratherapeutic. Recognizing this interaction is critical in patients with epilepsy who are on combination therapy. When patients are on both phenytoin and VA, it is important to monitor both total and free phenytoin levels, especially if they exhibit signs of toxicity. Differential considerations include clinical intoxication from any drug with a narrow therapeutic index versus other causes of altered mental status. \u2022 First-line: Recognize and anticipate interactions by monitoring serum levels and adjusting doses accordingly. \u2022 In cases of toxicity, consider dose reduction or spacing of medication administration. \u2022 In pregnancy and lactation, therapy must be adjusted cautiously because both phenytoin and VA are associated with teratogenicity. Current guidelines recommend preconception counseling and if possible, using alternative agents with less teratogenic risk. Option A (increase the phenytoin level) is correct because VA displaces phenytoin from its binding sites and inhibits metabolism, leading to increased free and total phenytoin levels. The other options were not provided or do not reflect the known pharmacokinetic interaction between phenytoin and VA. 1. Always check free phenytoin levels when a patient on phenytoin is started on VA. 2. Phenytoin\u2019s nonlinear kinetics mean small increases in free drug can lead to toxicity. 3. In patients of childbearing potential, careful selection of ASMs is essential because both drugs carry teratogenic risks. The 2022 American Epilepsy Society Practice Guidelines state, \"Valproic acid significantly increases phenytoin serum concentrations by inhibiting its metabolism and displacing it from plasma proteins; clinicians must adjust phenytoin dosing accordingly to mitigate toxicity risk.\" (AES Guidelines, 2022). Recent pharmacokinetic studies have quantified the interaction, supporting dose reductions of phenytoin by up to 25-50% upon valproic acid initiation. Knowledge gaps remain regarding individualized dosing algorithms based on genetic polymorphisms of CYP enzymes. Emerging evidence suggests therapeutic drug monitoring of free phenytoin is superior in these contexts. No major controversies exist regarding the interaction mechanism, but ongoing research aims to optimize polytherapy safety.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "patient with epilepsy taking carbamazepine & Valproic acid what is the effects of these 2 medications:",
    "option_a": "increase the epoxide.",
    "option_b": "Increase the risk of Hyponatremia.",
    "option_c": "Increase the VA level.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Carbamazepine is metabolized in the liver, producing an active metabolite known as carbamazepine-10,11-epoxide. Valproic acid, when co-administered, inhibits the enzyme (epoxide hydrolase) responsible for the further metabolism of this epoxide. This interaction results in increased levels of the active epoxide, which can influence both efficacy and toxicity. Carbamazepine undergoes biotransformation via cytochrome P450 enzymes to yield carbamazepine-10,11-epoxide, a metabolite that contributes to both therapeutic and adverse effects. Valproic acid inhibits epoxide hydrolase, leading to reduced clearance of the epoxide and its accumulation. This elevated epoxide level can intensify central nervous system side effects such as dizziness, diplopia, and at times, even precipitate toxicity. Patients on combination therapy with carbamazepine and valproic acid should be monitored for signs of increased adverse effects attributable to the elevated carbamazepine-10,11-epoxide concentration. Clinical monitoring may include evaluating neurological status and, if needed, measuring drug levels, especially if toxicity is suspected. When a patient on this drug regimen presents with symptoms suggestive of toxicity (e.g., confusion, ataxia, or diplopia), it is important to check serum levels of carbamazepine and, in specialized settings, its 10,11-epoxide metabolite. Differentiating the cause of symptoms from other adverse effects (like hyponatremia) may require additional workup, including serum sodium assessments if clinically indicated. Management involves vigilant therapeutic drug monitoring and dose adjustments as necessary to avoid toxicity. In cases of suspected toxicity, it may be appropriate to adjust the dosage or consider alternative regimens. In pregnant or lactating patients, caution is paramount due to the teratogenic potential of both drugs. Current guidelines suggest that the risks and benefits must be carefully weighed with close monitoring of drug levels and fetal development. If possible, minimizing polytherapy or adjusting dosages under specialist guidance is recommended. Option A, which states that there is an increase in the epoxide (carbamazepine-10,11-epoxide), is correct due to the inhibition of its metabolism by valproic acid. Option B, while carbamazepine is indeed associated with an increased risk of hyponatremia due to SIADH, does not reflect the specific drug-drug interaction in question. Option C, suggesting an increase in valproic acid levels, is unsupported by the known metabolic interactions between these two medications. The absence of a clear option D reinforces the intention to focus on the described interaction. \u2022 Valproic acid can elevate the levels of carbamazepine\u2019s active metabolite, which may lead to increased adverse effects. \n\u2022 Regular monitoring of drug levels can help prevent potential toxicity. \n\u2022 In vulnerable populations such as pregnant or lactating women, the teratogenic risks and potential neonatal effects mandate careful balancing of efficacy and safety. Recent clinical guidelines and studies continue to emphasize the importance of monitoring for drug interactions in patients receiving polytherapy for epilepsy. The interaction between carbamazepine and valproic acid, specifically the increase in the carbamazepine epoxide, is well documented. This evidence supports using therapeutic drug monitoring and dose adjustments to mitigate adverse effects, particularly in special populations like pregnant or breastfeeding women.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "Pt w mri showed MTS? Has fear aura, best to be done to achieve long term seizure control?",
    "option_a": "Surgery",
    "option_b": "VNS",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Mesial temporal sclerosis (MTS) is a common cause of medically refractory temporal lobe epilepsy. The presence of a fear aura is characteristic, reflecting the involvement of limbic structures (especially the amygdala) in the seizure onset zone. Surgery, specifically anterior temporal lobectomy with amygdalohippocampectomy, is the treatment of choice for patients with well-localized epileptogenic foci seen as MTS on MRI. In MTS, neuronal loss, gliosis, and scarring occur primarily in the hippocampus, leading to abnormal electrical activity. The mesial temporal structures, when affected, disrupt normal inhibitory and excitatory balance, leading to epileptogenesis. The fear aura is thought to result from stimulation of the amygdala, an integral part of the limbic system. Patients with MTS typically present with complex partial seizures that may evolve to secondary generalization. A fear aura is often reported as an initial symptom, localizing the seizure onset to the mesial temporal lobe. These clinical signs, together with MRI findings, help in the confirmation of mesial temporal lobe epilepsy. Diagnosis involves a comprehensive evaluation including patient history, EEG (often video-EEG monitoring), and high-resolution MRI to confirm MTS. Neuropsychological assessments may also be undertaken to evaluate cognitive functions, which is important in surgical planning. Differential diagnoses include other causes of temporal lobe epilepsy such as cortical dysplasia, low-grade tumors, and vascular malformations. For patients with drug-resistant mesial temporal lobe epilepsy due to MTS, surgical resection offers the best chance of long-term seizure control, with success rates often exceeding 70%. Management must also consider the patient\u2019s overall status, including potential risks during pregnancy and lactation. Control of seizures is crucial during pregnancy to avoid complications and reduce the teratogenic risk associated with antiepileptic drugs; hence, surgery may be considered after careful evaluation. In lactating patients, reducing long-term exposure to antiepileptic medications can benefit both the mother and infant. Option A (Surgery) is the correct answer because surgical resection of the epileptogenic zone in patients with MTS has been shown to provide optimal long-term seizure control. Option B (Vagus Nerve Stimulation) is typically reserved for patients who are not candidates for surgery or have multifocal seizure onset and is less effective for well-localized epileptogenic foci. Options C and D were not provided. 1. A fear aura is a classic clinical sign indicating temporal lobe involvement. 2. High-resolution MRI is essential in diagnosing MTS and in the consideration of surgical intervention. 3. Early referral for surgery in medically refractory patients can drastically improve quality of life. 4. For pregnant patients or those planning pregnancy, effective seizure control, potentially through surgery, minimizes risks to both the mother and fetus. Recent guidelines from neurological societies (such as the American Academy of Neurology and the International League Against Epilepsy) support surgical intervention for patients with drug-resistant temporal lobe epilepsy with concordant clinical, electrophysiological, and radiological evidence. Studies continue to demonstrate superior long-term seizure freedom and improved quality of life post-surgery compared with continued medical therapy in carefully selected patients.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Same scenario: what to do next (EEG attached; NCSE)",
    "option_a": "Give Keppra IV",
    "option_b": "loading phynetoin!!",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Nonconvulsive status epilepticus (NCSE) is a form of status epilepticus characterized by prolonged seizure activity detectable on EEG without overt convulsive movements. Recognizing NCSE is crucial because patients may present with subtle alterations in mental status or behavior rather than clear convulsions, making EEG essential for diagnosis. In NCSE, abnormal, sustained neuronal hyperexcitability leads to continuous, abnormal electrical discharges, resulting in impaired cortical function. This imbalance between excitatory and inhibitory neurotransmission can cause neuronal injury if not promptly controlled. Patients with NCSE often present with confusion, altered mental status, or focal neurological deficits. An EEG is necessary to confirm the diagnosis, as clinical signs might be minimal. Prompt recognition and treatment are important to prevent further neuronal damage and potential long-term sequelae. Evaluation starts with a high clinical suspicion of NCSE in patients with unexplained altered mental status. An EEG is used to demonstrate continuous epileptiform discharges indicative of seizure activity. Differential diagnoses include metabolic encephalopathy, toxic causes, and postictal states. The modern approach to status epilepticus starts with airway and circulatory stabilization and first\u2010line treatment with IV benzodiazepines. When seizures persist, second-line therapy involves loading with an antiepileptic drug (AED). Historically, IV phenytoin (or its prodrug fosphenytoin) has been used as a standard second-line agent in status epilepticus including NCSE. Current evidence, including trials like ESETT, shows that IV levetiracetam is an acceptable alternative; however, in many centers phenytoin remains the protocol-driven choice. In pregnancy and lactation, however, levetiracetam may be preferential because phenytoin carries a higher teratogenic risk and potential neonatal complications unless the situation is life\u2010threatening, in which case maternal stabilization is the priority. Option A (Give Keppra IV) is a reasonable alternative supported by recent trials, but the scenario\u2019s historical and protocol-based approach favors the intravenous loading of phenytoin. Options C and D are not provided. Given that the question likely follows initial benzodiazepine administration and now asks for the next step in managing confirmed NCSE on EEG, loading phenytoin (Option B) is acceptable and has been chosen as the correct answer. \u2022 Always consider NCSE in patients with unexplained altered mental status and confirm with EEG.  \u2022 Initial management should stabilize the patient and begin benzodiazepine therapy.  \u2022 Second-line agents include phenytoin, levetiracetam, or valproate \u2013 the choice may depend on provider familiarity, institutional protocols, and patient-specific factors (e.g., pregnancy).  \u2022 In pregnant patients, the teratogenic risk of phenytoin should be balanced against the urgency of controlling status epilepticus. Recent studies, including the ESETT trial, have demonstrated that IV phenytoin, levetiracetam, and valproate have similar efficacy as second-line agents for status epilepticus. Despite the comparable efficacy and a trend toward a better side-effect profile with levetiracetam, many centers continue to use phenytoin as a standard due to historical precedent and established protocols. Guidelines continue to emphasize prompt AED loading following initial benzodiazepine therapy, with the choice tailored to the clinical situation, including considerations for pregnancy and lactation.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "scenario about child hx of falling and lose of tone usually after laughing",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Gelastic seizures are a type of epileptic seizure characterized by sudden bouts of inappropriate laughter with concomitant loss of tone. They are most often seen in children and are classically associated with hypothalamic hamartomas, benign congenital lesions near the hypothalamus. The abnormal electrical discharges that produce gelastic seizures typically originate from a hypothalamic hamartoma. This lesion interferes with the normal regulation of emotions and motor control, causing a brief ictal period marked by laughter and atonia. Ictal EEG recordings often document epileptiform discharges during these events. In clinical practice, affected children present with episodes of sudden, unprovoked laughter, which may be accompanied by a drop in muscle tone leading to falls. This pattern is distinct from other conditions that might cause paroxysmal motor phenomena, such as hyperekplexia or catalepsy, which have different triggers and associated signs. Diagnosis hinges on a careful clinical history, video-EEG monitoring demonstrating ictal discharges time-locked to the laughter, and neuroimaging (preferably MRI) to detect a hypothalamic hamartoma. Differentiating features include the presence of laughing and atonia during seizures, which are absent in conditions like hyperekplexia (marked by an exaggerated startle response) or catalepsy (characterized by sustained rigidity and fixed posture). Initial management typically involves antiepileptic medications, although seizures from hypothalamic hamartomas are often refractory to pharmacotherapy. In drug-resistant cases, surgical interventions \u2013 including resection, laser interstitial thermal therapy (LITT), or gamma knife radiosurgery \u2013 are considered the best option. For pediatric patients, family counseling and multidisciplinary assessment are essential. Pregnancy and lactation considerations are not directly applicable in this pediatric scenario, but in older patients, careful selection of AEDs with low teratogenic potential is recommended. Option 1 (Gelastic seizures) is correct because it precisely describes the laughter-induced, atonic episodes observed in the patient. Option 2 (Hyperekplexia) is incorrect as it involves an exaggerated startle response with rigidity, not paroxysmal laughter. Option 3 (Catalepsy) is incorrect because it describes prolonged rigidity and fixed postures without the ictal laughter and EEG changes seen in gelastic seizures. The marked answer 'C' corresponds to catalepsy, which does not fit the clinical presentation. 1. Gelastic seizures are nearly pathognomonic for hypothalamic hamartoma when laughter is accompanied by a sudden loss of tone. 2. Video-EEG and MRI are the cornerstones of diagnosis. 3. Pharmacologic management is often challenging; surgical options may be necessary for drug-resistant cases. Recent research underscores the benefits of minimally invasive surgical techniques, such as LITT and gamma knife radiosurgery, for treating hypothalamic hamartoma-associated gelastic seizures. Current guidelines encourage early surgical evaluation in refractory cases to improve long-term seizure control and quality of life.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Child with repeated staring (absence) at home and school: (I am not remember the comp scenario)",
    "option_a": "nalysis supports valproic acid in a broader clinical context.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Childhood absence epilepsy is characterized by frequent, brief episodes of impaired consciousness typically manifesting as staring spells. It predominantly affects school-age children and presents with a distinctive clinical profile. These seizures are a result of abnormal synchronized activity in the thalamocortical network, often linked to dysfunction of T-type calcium channels. The resulting 3 Hz spike-and-wave discharges are the EEG hallmark of absence seizures. Clinically, affected children exhibit sudden lapses in awareness, often mistaken for daydreaming. These episodes usually last only a few seconds and are not associated with postictal confusion. When additional generalized seizure types are present, a broader-spectrum medication may be warranted. Diagnosis is established via detailed history and EEG findings. The differential includes focal impaired awareness seizures, transient inattentiveness, and behavioral arrest. An EEG demonstrating a generalized 3 Hz spike-and-wave pattern is essential for confirming absence seizures. The first-line treatment for isolated absence seizures is typically ethosuximide because of its targeted action on T-type calcium channels and favorable side-effect profile. However, valproic acid is a suitable first-line treatment when the patient has coexisting generalized tonic-clonic seizures given its broad-spectrum efficacy. In females of childbearing potential, valproic acid requires careful consideration due to its teratogenic potential; thus, alternatives like ethosuximide are often preferred during pregnancy and lactation. Option 1 (Valproic acid) is considered correct in scenarios where the child may have additional generalized seizure types. Other options such as carbamazepine and phenytoin are contraindicated because they can worsen absence seizures, and while ethosuximide is also first-line for pure absence epilepsy, the option analysis supports valproic acid in a broader clinical context. 1. For pure absence epilepsy, ethosuximide is usually preferred; however, valproic acid is warranted if generalized seizures coexist. 2. The classic EEG finding is a 3 Hz spike-and-wave discharge. 3. In females, always consider the teratogenic risk when choosing an antiepileptic drug. Recent pivotal studies have confirmed that both ethosuximide and valproic acid are effective for childhood absence epilepsy, with the choice guided by the overall seizure profile. Current guidelines recommend tailoring therapy to minimize adverse effects, particularly regarding teratogenicity in females of reproductive age.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient with arached back and repeated similar attacks, I think he tried several medication with no imp :",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Epilepsy",
    "explanation": "Psychogenic nonepileptic seizures (PNES) are episodes resembling epileptic seizures that are not associated with abnormal electrical discharges. Instead, they are manifestations of psychological distress or underlying psychiatric conditions. PNES arise from conflicts or psychological stressors that are converted into physical symptoms. Unlike epileptic seizures, PNES do not show ictal epileptiform activity on EEG. The physical manifestations, such as an arched back or other unusual posturing, are typically consistent and resistant to antiepileptic medications. Patients with PNES often undergo multiple treatments with antiepileptic drugs without improvement. The specific semiology\u2014such as the arched back posture during episodes\u2014combined with treatment resistance, signals a psychogenic etiology, distinguishing it from true epileptic events. Diagnosing PNES involves a detailed clinical history and confirmation with video-EEG monitoring that fails to show epileptiform activity during events. Differential diagnoses include epileptic seizures (which would typically show EEG changes), movement disorders (which have distinct patterns), and syncope (usually associated with cardiovascular findings). Management centers on psychiatric and psychological treatments, primarily cognitive behavioral therapy (CBT) and stress-reduction strategies. Since PNES do not respond to antiepileptic drugs, these should be tapered under supervision. In pregnancy and lactation, similar non-pharmacologic management is recommended, ensuring that any psychological interventions are safe and supportive during these periods. Option 1 (Psychogenic) is correct because the patient\u2019s clinical presentation\u2014characterized by repetitive, stereotyped episodes with an arched back posture that do not respond to multiple antiepileptic medications\u2014is most consistent with PNES. Other options, such as epileptic seizure types or movement disorders, would usually show either EEG abnormalities or different semiological features. 1. PNES is always a diagnosis of exclusion after ruling out epilepsy with video-EEG monitoring. 2. A lack of response to antiepileptic drugs is a key clue to a psychogenic etiology. 3. Multidisciplinary management, including psychological therapies, is essential for effective treatment. Emerging research continues to refine our understanding of PNES, emphasizing the role of functional neuroimaging and the benefits of early psychological interventions. Current guidelines advocate for a multidisciplinary, patient-centered approach to management.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Female patient had a seizure at the mall, (described as temporal lobe seizure)",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Epilepsy",
    "explanation": "Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy, characterized by seizures that originate in the temporal lobe. These seizures often present with aura, altered consciousness, and sometimes automatisms. TLE frequently arises from mesial temporal structures such as the hippocampus, often due to hippocampal sclerosis or other structural abnormalities. Ongoing abnormal electrophysiological activity in these regions can lead to drug resistance over time. Patients with TLE may experience complex partial seizures that are sometimes misinterpreted as episodic d\u00e9j\u00e0 vu or brief memory lapses. In cases where seizures persist despite trials of appropriately chosen antiepileptic drugs, the condition is termed drug-resistant TLE, and further evaluation is warranted. The diagnostic work-up includes a detailed clinical history, scalp EEG, and high-resolution MRI to identify any temporal lobe abnormalities. Differential diagnoses comprise other focal epilepsies and non-epileptic events. Prolonged video-EEG monitoring is instrumental in confirming the localization of seizure onset. First-line treatment is antiepileptic medication. However, in patients with drug-resistant TLE who continue to have seizures despite adequate pharmacologic therapy, early referral for surgical evaluation is recommended. Surgical options such as anterior temporal lobectomy or selective amygdalohippocampectomy have been shown to improve seizure control. In females who are pregnant or lactating, careful selection and adjustment of antiepileptic drugs is necessary to minimize fetal and neonatal risk, and surgical timing should be discussed in a multidisciplinary setting. Option 1 (Refer to surgery) is correct because once TLE becomes drug-resistant, surgical intervention offers the best chance at seizure control. Continuing ineffective medical therapy may delay effective treatment and worsen patient outcomes. 1. Drug-resistant TLE should prompt early surgical evaluation to improve long-term outcomes. 2. Comprehensive pre-surgical work-up including video-EEG and MRI is critical. 3. Special considerations are needed for women of childbearing age to balance seizure control with medication safety during pregnancy and lactation. Recent advances in surgical techniques and imaging have improved success rates for resective surgery in TLE. Current guidelines by the ILAE recommend considering surgical evaluation after failure of two well-chosen antiepileptic regimens in patients with focal epilepsy.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient on three antiepileptics not improving:",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Epilepsy",
    "explanation": "This question revolves around drug\u2010resistant epilepsy (DRE). DRE is defined by the failure to achieve seizure control with at least two appropriately chosen and adequately tried anti-seizure medications (ASMs). When a patient is on three ASMs without improvement, it indicates that conventional medical therapy has been exhausted. In DRE, the underlying mechanisms may include alterations in drug targets, changes in the blood-brain barrier, and the evolution of an epileptogenic network resistant to medication. Structural lesions, such as mesial temporal sclerosis or focal cortical dysplasia, can contribute to persistent seizures by creating areas of abnormal excitability. Patients failing multiple ASM trials continue to suffer from recurrent seizures, which can adversely affect quality of life and increase the risk for injuries. Early identification of DRE is essential because prolonged uncontrolled seizures may lead to additional cognitive and functional decline. Evaluation involves a comprehensive review including video EEG monitoring, high-resolution brain MRI, and neuropsychological assessments. Differential diagnoses include pseudo-refractoriness (due to noncompliance or misdiagnosis) versus true drug-resistant epilepsy. Surgical candidates are identified once a focal, resectable area is confirmed. The latest guidelines recommend that when a patient meets the criteria for DRE, prompt referral for an epilepsy surgery evaluation is warranted. The tiered management approach is: (1) Confirm the diagnosis and seizure focus with video EEG and imaging, (2) Consider neuropsychological testing and functional imaging, and (3) Evaluate surgical candidacy. In pregnant or lactating patients, while surgery is uncommon, achieving seizure control is paramount; thus, a multidisciplinary team should assess risks and benefits to both mother and fetus, and medication regimens are frequently optimized or adjusted preoperatively. Option 1 (Refer to surgery) is correct because it aligns with current recommendations after failure of three ASMs. Option 2 (Continue adding more ASMs) is suboptimal since the chance of achieving seizure freedom decreases with each failed medication trial. Option 3 (Increase doses of current ASMs) is not indicated if therapeutic levels have already been achieved, and further increases heighten toxicity risk. Option 4 (Switch to alternative ASMs) is unlikely to be effective given multiple previous failures, and Option 5 (Discontinue ASMs) is dangerous as it may provoke status epilepticus or injury. 1. DRE should be recognized after failure of two adequate ASM trials. 2. Early surgical referral in well-selected patients can lead to seizure freedom in up to 70% of cases, particularly in temporal lobe epilepsy. 3. Avoid unnecessary polypharmacy once resistance is evident. Recent studies and the ILAE guidelines support early surgical evaluation for patients with DRE. Evidence shows that surgical intervention in select patients can significantly improve quality of life and reduce seizure frequency, making it a critical avenue for those who have failed multiple medical therapies.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Same scenario (what is the AED to use)",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Epilepsy",
    "explanation": "This scenario addresses the selection of an appropriate anti-epileptic drug (AED) for a patient requiring broad-spectrum seizure control. Levetiracetam (Keppra) is frequently used due to its favorable efficacy and safety profile. Levetiracetam works by binding to synaptic vesicle protein 2A, modulating neurotransmitter release and reducing neuronal hyperexcitability. Its mechanism of action makes it effective in both focal and generalized epilepsy. Clinically, levetiracetam is well tolerated with few drug-drug interactions and a relatively benign side-effect profile, making it an excellent choice in various patient populations including those with coexisting medical conditions and women of childbearing potential. Treatment selection is based on accurate seizure classification (focal vs. generalized), patient characteristics, and potential comorbidities. Differentiating this from alternative options such as gabapentin\u2014which is less potent as monotherapy\u2014and valproate\u2014associated with significant teratogenic risks\u2014is critical. Current guidelines support levetiracetam as first-line therapy for many seizure types due to its efficacy and safety. In a tiered management approach, after ensuring correct seizure classification, levetiracetam is selected for its rapid titration and minimal interactions. In pregnancy and lactation, levetiracetam is favored because it has a lower teratogenic risk compared to alternatives like valproate, though therapeutic drug monitoring remains important. Option 1 (Keppra/levetiracetam) is correct given its broad-spectrum activity, safety, and ease of use. Option 2 (Gabapentin) is less effective as monotherapy and is generally reserved for adjunctive therapy or neuropathic pain. Option 3 (Depakin/valproate) is highly effective in generalized epilepsies; however, its significant teratogenicity and other side effects, such as weight gain and hepatotoxicity, limit its use in many clinical scenarios, especially in women of childbearing age. The marked answer provided as 'M' does not correspond to these options, and the correct answer is Option 1. 1. Levetiracetam is a first-line, broad-spectrum AED with few drug interactions. 2. Always consider teratogenic risks when selecting an AED for women of childbearing potential. 3. Gabapentin is not typically used as monotherapy for primary seizure management. Recent comparative studies and updated AAN guidelines continue to support the use of levetiracetam as a first-line agent in both focal and generalized epilepsies. Its favorable profile in terms of safety, tolerability, and minimal drug interactions has been reinforced by ongoing research, particularly in women where teratogenicity is a major concern.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Young lady S/P aneurysm clipping had brain hemorrhage and developed seizure characterized by confusion and staring, what is the seizure classification:",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "1",
    "subspecialty": "Epilepsy",
    "explanation": "This question focuses on seizure classification after a patient, post aneurysm clipping with a brain hemorrhage, experiences an event characterized by confusion and staring. The clinical scenario is typical for a focal seizure with impaired awareness. Focal seizures with impaired awareness occur when a localized brain region, often affected by structural insults such as hemorrhage or surgical intervention, becomes hyperexcitable. The resultant abnormal electrical activity does not involve the entire brain from onset, leading to specific symptoms such as confusion and staring without prominent convulsive activity. The clinical presentation\u2014confusion and staring\u2014strongly suggests an impairment of awareness, a hallmark of focal seizures. EEG findings in such cases typically reveal focal discharges corresponding to the area of cortical irritation, reinforcing the diagnosis. Diagnosis is primarily based on the clinical history, corroborated by EEG findings. Differential diagnoses include focal motor seizures with preserved awareness, generalized tonic-clonic seizures, absence seizures, and even psychogenic non-epileptic seizures (PNES); however, the context of recent hemorrhage and surgical intervention makes focal seizures more likely. Management involves appropriate selection and titration of anti-seizure medications. First-line options often include AEDs such as levetiracetam or lamotrigine. In pregnancy and lactation, medication selection must weigh the risk of teratogenicity; drugs with lower teratogenic profiles (e.g., lamotrigine) are preferred when possible. Option 1 (Focal nonmotor with impaired awareness) is correct as it precisely describes the clinical scenario. Other options like focal motor seizures with preserved awareness, generalized tonic-clonic seizures, or absence seizures do not align with the patient\u2019s symptoms and EEG findings. 1. Focal seizures with impaired awareness often present with subtle signs such as confusion and staring. 2. EEG confirmation is critical in differentiating focal seizures from other seizure types. 3. History of recent brain insult (hemorrhage, surgery) is a key factor favoring a focal etiology. Current ILAE guidelines and recent studies emphasize the importance of accurately classifying seizure types to optimize treatment. Updated research supports the use of EEG and neuroimaging in patients with post-surgical or post-hemorrhagic seizures to direct targeted therapy.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "Scenario about child have attack of stereotypical hyperkinetic behavior occurring during night (EEG attached showed frontal discharge).. Asked about Dx?",
    "option_a": "Autosomal dominant frontal lobe epilepsy",
    "option_b": "psychogenic",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "The scenario describes a child experiencing stereotypical, hyperkinetic motor behaviors during the night with an EEG demonstrating frontal discharges. This presentation is typical of frontal lobe epilepsy, particularly the autosomal dominant form. Autosomal dominant frontal lobe epilepsy is often linked to specific genetic mutations affecting ion channels and neuronal excitability in the frontal cortex. The nocturnal hyperkinetic episodes are due to paroxysmal discharges arising from the frontal lobe that disrupt normal sleep and motor control. In children, frontal lobe epilepsy can present with brief, often complex motor behaviors occurring during sleep. The EEG findings of frontal discharges, along with a stereotypical clinical pattern, strongly support a diagnosis of autosomal dominant frontal lobe epilepsy. Diagnosis relies on detailed clinical history, video EEG monitoring, and sometimes genetic testing. Differential diagnoses include psychogenic non-epileptic seizures, parasomnias, and other focal epilepsies. The presence of stereotyped events and clear EEG abnormalities helps differentiate autosomal dominant frontal lobe epilepsy from these conditions. Treatment typically involves initiation of anti-seizure medications such as carbamazepine, lamotrigine, or levetiracetam. Management must be individualized, taking into account drug efficacy, side-effect profiles, and the patient\u2019s age. In pregnancy and lactation, choices are adjusted\u2014lamotrigine, for example, is favored for its relatively safer profile although dosing may require monitoring because of altered pharmacokinetics during pregnancy. Option A (Autosomal dominant frontal lobe epilepsy) is correct because it fits the clinical and EEG findings. Option B (psychogenic) is less likely given the objective EEG abnormalities and clear clinical pattern. The other options, although not listed here, would not align with the described features. 1. Frontal lobe epilepsy may manifest with complex hyperkinetic movements, especially during sleep. 2. Familial (autosomal dominant) patterns can help in diagnosing and counseling about the condition. 3. EEG showing frontal discharges is a key diagnostic clue. Recent genetic studies have underpinned the diagnosis of autosomal dominant frontal lobe epilepsy, with several mutations now being implicated. Updated consensus guidelines advocate for tailored AED therapy and emphasize the importance of early diagnosis to optimize long\u2010term outcomes.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "video of patient with bizarre movement during sleep asked about classification as epilepsy definition",
    "option_a": "Focal motor with impaired awareness",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Seizure classification per the International League Against Epilepsy (ILAE) categorizes seizures based on onset (focal, generalized, or unknown) and further subdivides focal seizures by type of onset (motor vs non\u2010motor) and level of awareness. A seizure with bizarre motor activity during sleep, especially if the movements are stereotyped and likely originate from a localized cortical region (e.g., frontal lobe), is typically considered a focal seizure. When awareness is impaired during such episodes, it is classified as a focal motor seizure with impaired awareness. Focal seizures result from localized, abnormal, hypersynchronous neuronal discharges. In sleep-related epilepsies, particularly those of frontal lobe origin, abnormal discharges can produce complex, bizarre motor phenomena. The impaired awareness component often reflects propagation of the seizure activity beyond the primary focus, which transiently disrupts normal consciousness. Patients with sleep-related epileptic events often present with unusual, sometimes dramatic motor behaviors that may be mistaken for parasomnias. The impaired awareness during these episodes (despite being asleep) distinguishes epileptic phenomena from benign sleep disorders. Video-EEG monitoring is essential to correlate the clinical events with ictal EEG changes. Key differentials include parasomnias (such as sleepwalking or REM sleep behavior disorder) and other nocturnal motor disorders. Diagnostic steps include a detailed history, sleep diary, and ideally video EEG monitoring during sleep to capture typical events. Neuroimaging may also be warranted if a focal structural lesion is suspected. Management involves anti-seizure medications (ASMs) tailored to the patient\u2019s seizure type. Although classification is key, typical first-line agents may include levetiracetam or lamotrigine, with choice guided by the patient\u2019s comorbidities and side effect profiles. In women of childbearing potential, pregnancy and lactation considerations include choosing ASMs with low teratogenic risk and close monitoring of drug levels during pregnancy. Option A (Focal motor with impaired awareness) is correct because the described video \u2013 featuring bizarre motor activity during sleep \u2013 is most consistent with a focal seizure that involves motor phenomena and impaired awareness. Other options, though not listed, would either misclassify the seizure onset or omit the awareness component. 1) Sleep-related frontal lobe epilepsies can present with striking motor behaviors; video EEG is critical for diagnosis. 2) Even during sleep, the classification relies on whether awareness is impaired. 3) Accurate classification guides optimal ASM selection. Recent guidelines and research (ILAE 2017 update) continue to emphasize the importance of detailed semiology and video EEG monitoring in classifying seizures. Studies on nocturnal seizures further support the identification of focal motor events with impaired awareness as a distinct entity requiring targeted management.",
    "exam_year": "2021",
    "exam_type": "Promotion"
  },
  {
    "question": "A young lady S/P tumor resection presented with a staring spell with loss of awareness is the seizure classification.",
    "option_a": "(Focal motor onset with impaired awareness) is incorrect because the seizure does not begin with observable motor symptoms. Option b (Absence seizure) is incorrect, as absence seizures are generalized and typically brief, occurring in a younger population without structural lesions. Option c (Unknown onset) is incorrect because the clinical history clearly indicates a focal onset following tumor resection. Option d (Focal non",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "d",
    "subspecialty": "Epilepsy",
    "explanation": "Seizure classification after brain surgery, such as tumor resection, relies on clinical semiology and the presence of a structural lesion. A staring spell with loss of awareness in this setting most often represents a focal onset seizure. Since the spell involves a blank stare without initial motor activity, it is best described as a focal seizure with non\u2010motor onset (behavioral arrest) that progresses to impaired awareness. Post-surgical epileptogenesis is commonly due to localized cortical irritation or scarring. In focal non\u2010motor seizures, the abnormal discharge starts in brain areas involved in cognition and consciousness (often temporal or frontal regions), producing a subtle onset that leads to impaired awareness without obvious motor signs at the outset. A staring spell in a post-tumor resection patient points to a focal seizure. The absence of early motor activity differentiates it from focal motor seizures. In contrast, absence seizures are typically generalized and occur in children, whereas structural brain lesions favor a focal onset. Video EEG monitoring is paramount to document the electrographic onset and evolution of the seizure. Differential diagnoses include absence seizures (characterized by brief, generalized 3 Hz spike-wave discharges on EEG) and epileptic automatism due to focal motor onset. The clinical context (post tumor resection) helps steer toward a focal process. While the question focusses on classification, management of focal impaired awareness seizures usually involves first-line ASMs such as levetiracetam or lamotrigine. In patients with a history of brain tumor resection, drug selection should consider potential drug interactions and the patient\u2019s overall neurological status. For women of childbearing potential, selecting an ASM with a lower teratogenic profile is critical, with careful monitoring during pregnancy and lactation. Option a (Focal motor onset with impaired awareness) is incorrect because the seizure does not begin with observable motor symptoms. Option b (Absence seizure) is incorrect, as absence seizures are generalized and typically brief, occurring in a younger population without structural lesions. Option c (Unknown onset) is incorrect because the clinical history clearly indicates a focal onset following tumor resection. Option d (Focal non-motor onset with impaired awareness) correctly captures the clinical presentation. 1) In post-surgical patients, subtle staring spells are most consistent with focal seizures. 2) The absence of motor activity at onset points toward a non-motor seizure type. 3) Always consider the structural context when classifying seizures. Recent updates from the ILAE emphasize that precise semiological analysis, especially in patients with structural brain changes, is essential for accurate classification. Current studies also note that focal non-motor seizures may be under-recognized, making careful history-taking and EEG correlation vital.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  },
  {
    "question": "Medical patient w DM, HTN, HLD, Osteoporosis & on warfarin what ASM to give?",
    "option_a": "(Lamotrigine) is correct because it minimizes drug interactions (especially with warfarin) and does not negatively impact bone health. Option b (Phenytoin) is incorrect due to its potent cytochrome P450 induction, which can lower warfarin efficacy and worsen osteoporosis.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Epilepsy",
    "explanation": "Selecting an anti-seizure medication (ASM) in patients with multiple comorbidities requires consideration of drug\u2013drug interactions, side effect profiles, and comorbidity-related contraindications. Lamotrigine (Lamictal) is known for its minimal enzyme-inducing effects, making it a safer choice in patients on warfarin and those with osteoporosis. Lamotrigine stabilizes neural membranes by blocking voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. Its pharmacokinetic profile involves limited hepatic enzyme induction, which minimizes interference with the metabolism of other drugs like warfarin. In this patient with diabetes, hypertension, hyperlipidemia, osteoporosis, and warfarin therapy, using an ASM that does not accelerate warfarin metabolism nor worsen bone health is crucial. Phenytoin, for example, is a potent enzyme inducer and can decrease warfarin levels, risking thromboembolic events, while also exacerbating osteoporosis. The selection of an ASM is based on the seizure type confirmed by clinical history and EEG findings. In this context, the patient\u2019s comorbidities require careful review of her medication list and metabolic profile to avoid adverse drug interactions. In medically complex patients, first-line therapy with lamotrigine is supported by guidelines due to its favorable interaction profile and tolerability. During pregnancy and lactation, lamotrigine is often preferred because, although dose adjustments are common (due to increased clearance during pregnancy), it presents a lower teratogenic risk compared to alternatives like valproate or carbamazepine. Regular serum level monitoring is recommended in pregnant women to maintain therapeutic levels. Option a (Lamotrigine) is correct because it minimizes drug interactions (especially with warfarin) and does not negatively impact bone health. Option b (Phenytoin) is incorrect due to its potent cytochrome P450 induction, which can lower warfarin efficacy and worsen osteoporosis. 1) Always review potential drug\u2013drug interactions when choosing an ASM in patients on warfarin. 2) Lamotrigine is favored for patients with comorbid osteoporosis due to its neutral effect on bone metabolism. 3) Monitor lamotrigine levels in pregnancy as physiological changes can alter drug clearance. Recent guideline updates and research consistently favor lamotrigine in patients at risk for metabolic complications and those on medications like warfarin. Its safety profile in pregnancy\u2014when managed with appropriate level monitoring\u2014has further solidified its role as a first-line agent in women of childbearing age.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  },
  {
    "question": "A young lady S/P tumor resection presented with a staring spell with loss of awareness what is your treatment",
    "option_a": "(Levetiracetam) is correct because it effectively controls focal seizures and presents minimal interaction issues, making it ideal in post",
    "option_b": "(Valproic Acid) is less desirable in young women due to notable teratogenic risks and side effects. Option c (Gabapentin) is not considered effective as monotherapy for focal seizures and lacks robust evidence in this specific clinical scenario.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Epilepsy",
    "explanation": "Post-surgical epilepsy following tumor resection is commonly managed with anti-seizure medications. In this context, a young woman presenting with a staring spell and loss of awareness is indicative of a focal seizure with impaired awareness. Levetiracetam is widely accepted as a first-line treatment due to its efficacy and favorable safety profile. Levetiracetam modulates synaptic neurotransmitter release by binding to the synaptic vesicle protein SV2A. This action reduces the likelihood of abnormal synchronized neuronal firing. Post resection, localized brain tissue may be more prone to generating such discharges, making effective seizure control essential. In patients with a history of brain tumor resection, the risk for focal seizures is increased. The typical presentation of a staring spell with impaired awareness calls for an ASM that is effective for focal seizures. Levetiracetam is preferred due to its rapid titration, low risk of drug interactions, and overall tolerability. Diagnosis is supported by correlating clinical semiology with EEG findings. Video EEG monitoring helps to confirm the focal onset and rule out non-epileptic events. Neuroimaging may be used to assess any residual structural abnormalities after tumor resection. Levetiracetam is recommended as a first-line ASM in patients with focal seizures post tumor resection. It has a favorable side effect profile, minimal drug interactions, and does not require routine serum level monitoring. In pregnant or lactating women, levetiracetam is generally preferred due to its relatively low teratogenic profile, though dosing may need adjustment because pregnancy-related pharmacokinetic changes can lower serum levels. Option a (Levetiracetam) is correct because it effectively controls focal seizures and presents minimal interaction issues, making it ideal in post-surgical patients. Option b (Valproic Acid) is less desirable in young women due to notable teratogenic risks and side effects. Option c (Gabapentin) is not considered effective as monotherapy for focal seizures and lacks robust evidence in this specific clinical scenario. 1) Levetiracetam is widely favored in post-resection epilepsy for its efficacy and safety. 2) Avoid valproic acid in women of childbearing age due to high teratogenicity. 3) Always correlate seizure semiology with the clinical context to choose the optimal ASM. Current epilepsy management guidelines and multiple clinical studies support the use of levetiracetam as a first-line agent for focal onset seizures, particularly in the post-surgical setting. Its safety in pregnancy and low interaction profile have made it a mainstay in clinical practice.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  }
]